Left ventricular non-compaction cardiomyopathy mimicking an infiltrative cardiac disease

Insights

This study highlights left ventricular hypertrabeculation-noncompaction (LVNC) mimicking infiltrative heart disease. Contrast echocardiography is crucial for diagnosing LVNC, preventing misdiagnosis of conditions like cardiac amyloidosis.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Cardiovascular Diseases

Background:

  • A 60-year-old male with a history of coronary artery bypass graft presented for cardiologic evaluation.
  • Routine echocardiography revealed significant left ventricular hypertrophy, mimicking infiltrative myocardial disease such as cardiac amyloidosis.
  • Standard echocardiographic criteria for left ventricular non-compaction cardiomyopathy (LVNC) were not met.

Observation:

  • Asymmetric wall thickening prompted further investigation with left heart contrast echocardiography.
  • Deep intertrabecular recesses were unmasked in the anterolateral and inferolateral segments.
  • This revealed features consistent with left ventricular hypertrabeculation-noncompaction (LVNC).

Findings:

  • Left ventricular hypertrabeculation-noncompaction (LVNC) is a rare abnormality characterized by excessive trabeculations and perfused intertrabecular spaces.
  • This case is the first reported instance of LVNC mimicking infiltrative myocardial disease on echocardiography.
  • The findings underscore a potential diagnostic pitfall in identifying LVNC.

Implications:

  • Accurate diagnosis of LVNC is essential for appropriate patient management.
  • Left ventricular opacification agents can aid in unmasking LVNC, especially in atypical presentations.
  • This case emphasizes the importance of advanced imaging techniques to avoid misdiagnosis of cardiac conditions.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...